Loftus Peak
RVMD icon

Loftus Peak’s Revolution Medicines RVMD Stock Holding History

Loftus Peak’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.5M Sell
94,803
-1,291
-1% -$256K 2.49% 18
2026
Q2 		$18M Buy
+96,094
New +$14M 2.45% 17

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Loftus Peak's RVMD Position: Q3 2026 in Review

Loftus Peak reduced its Revolution Medicines (RVMD) stake by 1.3% in Q3 2026, selling an estimated $256K and leaving 94,803 shares worth $19.5M. The position accounts for 2.49% of the portfolio, ranked #18.

Loftus Peak first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Loftus Peak held 94,803 shares of Revolution Medicines worth $19.5M as of Q3 2026.
  • Loftus Peak sold 1,291 Revolution Medicines shares in Q3 2026, an estimated $256K.
  • Revolution Medicines made up 2.49% of Loftus Peak's portfolio in Q3 2026, its #18 holding.
  • Loftus Peak first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Loftus Peak's 13F filing for Q3 2026, filed 15 Oct 2026.